Post-Approval Study of MelaFind

Stopped early

Conditions studied: Melanoma

In brief

The purpose of this study is to collect data to describe the real-world use and safety and effectiveness of MelaFind® in a post-approval clinical setting.

Key facts

Study ID
NCT01700114
Run by
MELA Sciences, Inc.
People needed
487
Starts
2012-11-01
Expected to finish
2016-01-01
Last updated by the study team
2016-03-11

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.